Atrial fibrillation in ß-thalassemia Major Patients: Diagnosis, Management and Therapeutic Options.
Hemoglobin
; 42(3): 189-193, 2018 May.
Article
in En
| MEDLINE
| ID: mdl-30270686
ABSTRACT
The prevalence of atrial fibrillation (AFib) in ß-thalassemia major (ß-TM) patients has increased in the last few years, reaching up to 33.0%. Several factors may drive this value to even more in the next few years. We summarized the main challenges in the management and therapy of AFib in this very specific group of patients.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Atrial Fibrillation
/
Beta-Thalassemia
Type of study:
Diagnostic_studies
/
Prevalence_studies
Limits:
Humans
Language:
En
Journal:
Hemoglobin
Year:
2018
Document type:
Article
Affiliation country:
Reino Unido